Chinese scientist He Jiankui’s November 2018 announcement of creating world’s first gene-edited babies sparked global outrage, ethical condemnation, and his eventual imprisonment, highlighting genetic engineering’s governance challenges.
The Rogue Experiment
He Jiankui announced at Hong Kong conference that he’d used CRISPR to edit CCR5 gene in twin embryos (later revealed third baby born), claiming to make them HIV-resistant. The scientific community reacted with horror: the editing was medically unnecessary (existing HIV prevention methods work), potentially harmful (unknown effects), violated ethical norms, and broke Chinese regulations. Twitter exploded with condemnation from geneticists worldwide, calling it premature, reckless, and crossing lines international moratorium aimed to prevent.
The International Response
The scandal triggered global debate about genetic engineering governance: if one scientist could ignore ethical guidelines, how could humanity prevent designer babies, genetic inequality, or eugenics? Countries rushed to strengthen regulations, international bodies issued statements, and calls grew for enforcement mechanisms beyond voluntary guidelines. The incident demonstrated that scientific self-regulation couldn’t prevent rogue actors, requiring legal frameworks. However, international coordination remained elusive—no global authority could enforce standards across borders.
The Aftermath and Lessons
He Jiankui received 3-year prison sentence in China (2019), lost his positions, and became pariah in scientific community. The edited children’s long-term health remained unknown, raising ongoing ethical concerns about conducting experiment without knowing consequences. The scandal’s legacy included both stronger regulations and recognition that CRISPR’s accessibility meant bad actors couldn’t be entirely stopped—only detected and punished after damage done. Social media discussions shifted from whether germline editing should happen to how to govern it responsibly.
Sources: